
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19
Michael J. Peluso, J. Daniel Kelly, Scott Lu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 44
Michael J. Peluso, J. Daniel Kelly, Scott Lu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection
Destin Groff, Ashley Sun, Anna E. Ssentongo, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2128568-e2128568
Open Access | Times Cited: 878
Destin Groff, Ashley Sun, Anna E. Ssentongo, et al.
JAMA Network Open (2021) Vol. 4, Iss. 10, pp. e2128568-e2128568
Open Access | Times Cited: 878
Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 210-216
Open Access | Times Cited: 731
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 210-216
Open Access | Times Cited: 731
Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
César Fernández‐de‐las‐Peñas, Domingo Palacios‐Ceña, Víctor Gómez‐Mayordomo, et al.
European Journal of Internal Medicine (2021) Vol. 92, pp. 55-70
Open Access | Times Cited: 500
César Fernández‐de‐las‐Peñas, Domingo Palacios‐Ceña, Víctor Gómez‐Mayordomo, et al.
European Journal of Internal Medicine (2021) Vol. 92, pp. 55-70
Open Access | Times Cited: 500
Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Michael J. Peluso, Scott Lu, Alex Tang, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 11, pp. 1839-1848
Open Access | Times Cited: 261
Michael J. Peluso, Scott Lu, Alex Tang, et al.
The Journal of Infectious Diseases (2021) Vol. 224, Iss. 11, pp. 1839-1848
Open Access | Times Cited: 261
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, et al.
Cell Reports (2021) Vol. 36, Iss. 6, pp. 109518-109518
Open Access | Times Cited: 199
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, et al.
Cell Reports (2021) Vol. 36, Iss. 6, pp. 109518-109518
Open Access | Times Cited: 199
Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
Giandomenico Bisaccia, Fabrizio Ricci, Vittoria Recce, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 8, Iss. 11, pp. 156-156
Open Access | Times Cited: 107
Giandomenico Bisaccia, Fabrizio Ricci, Vittoria Recce, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 8, Iss. 11, pp. 156-156
Open Access | Times Cited: 107
Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: a systematic review and meta-analysis
César Fernández‐de‐las‐Peñas, Marcos José Navarro‐Santana, Gustavo Plaza‐Manzano, et al.
Pain (2021) Vol. 163, Iss. 7, pp. 1220-1231
Open Access | Times Cited: 101
César Fernández‐de‐las‐Peñas, Marcos José Navarro‐Santana, Gustavo Plaza‐Manzano, et al.
Pain (2021) Vol. 163, Iss. 7, pp. 1220-1231
Open Access | Times Cited: 101
Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
Bala Munipalli, Lynsey A. Seim, Nancy L. Dawson, et al.
SN Comprehensive Clinical Medicine (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 87
Bala Munipalli, Lynsey A. Seim, Nancy L. Dawson, et al.
SN Comprehensive Clinical Medicine (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 87
Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: A multicenter study
César Fernández‐de‐las‐Peñas, Domingo Palacios‐Ceña, Víctor Gómez‐Mayordomo, et al.
Journal of Infection (2021) Vol. 83, Iss. 2, pp. 237-279
Open Access | Times Cited: 70
César Fernández‐de‐las‐Peñas, Domingo Palacios‐Ceña, Víctor Gómez‐Mayordomo, et al.
Journal of Infection (2021) Vol. 83, Iss. 2, pp. 237-279
Open Access | Times Cited: 70
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis
Bang Zheng, Luke Daines, Qing Han, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220071-220071
Open Access | Times Cited: 57
Bang Zheng, Luke Daines, Qing Han, et al.
European Respiratory Review (2022) Vol. 31, Iss. 166, pp. 220071-220071
Open Access | Times Cited: 57
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
Michael J. Peluso, Matthew A. Spinelli, Tyler‐Marie Deveau, et al.
AIDS (2022) Vol. 36, Iss. 12, pp. F7-F16
Open Access | Times Cited: 50
Michael J. Peluso, Matthew A. Spinelli, Tyler‐Marie Deveau, et al.
AIDS (2022) Vol. 36, Iss. 12, pp. F7-F16
Open Access | Times Cited: 50
Post-acute COVID-19 symptom risk in hospitalized and non-hospitalized COVID-19 survivors: A systematic review and meta-analysis
Yuan Niu, Zhang-Hong Lv, Chunrong Sun, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 23
Yuan Niu, Zhang-Hong Lv, Chunrong Sun, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 23
Long-COVID Headache
Paolo Martelletti, Enrico Bentivegna, Valerio Spuntarelli, et al.
SN Comprehensive Clinical Medicine (2021) Vol. 3, Iss. 8, pp. 1704-1706
Open Access | Times Cited: 53
Paolo Martelletti, Enrico Bentivegna, Valerio Spuntarelli, et al.
SN Comprehensive Clinical Medicine (2021) Vol. 3, Iss. 8, pp. 1704-1706
Open Access | Times Cited: 53
Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France
Souheil Zayet, H. Zahra, Pierre‐Yves Royer, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1719-1719
Open Access | Times Cited: 51
Souheil Zayet, H. Zahra, Pierre‐Yves Royer, et al.
Microorganisms (2021) Vol. 9, Iss. 8, pp. 1719-1719
Open Access | Times Cited: 51
Immunological dysfunction persists for 8 months following initial mild-moderate SARS-CoV-2 infection
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 44
Chansavath Phetsouphanh, D.R. Darley, Daniel B. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 44
Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in Korea
Yoonjung Kim, Shin‐Woo Kim, Hyun‐Ha Chang, et al.
Infection and Chemotherapy (2021) Vol. 53, Iss. 3, pp. 463-463
Open Access | Times Cited: 40
Yoonjung Kim, Shin‐Woo Kim, Hyun‐Ha Chang, et al.
Infection and Chemotherapy (2021) Vol. 53, Iss. 3, pp. 463-463
Open Access | Times Cited: 40
Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue
Rakibul Hafiz, Tapan Kumar Gandhi, Sapna S. Mishra, et al.
Neuroimage Reports (2022) Vol. 2, Iss. 2, pp. 100095-100095
Open Access | Times Cited: 33
Rakibul Hafiz, Tapan Kumar Gandhi, Sapna S. Mishra, et al.
Neuroimage Reports (2022) Vol. 2, Iss. 2, pp. 100095-100095
Open Access | Times Cited: 33
Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
Matthew S. Durstenfeld, Michael J. Peluso, J. Daniel Kelly, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 33
Matthew S. Durstenfeld, Michael J. Peluso, J. Daniel Kelly, et al.
JCI Insight (2022) Vol. 7, Iss. 10
Open Access | Times Cited: 33
Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Ping-Heng Tan, Jasmine Ji, Chung‐Hsi Hsing, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14394-14394
Open Access | Times Cited: 33
Ping-Heng Tan, Jasmine Ji, Chung‐Hsi Hsing, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14394-14394
Open Access | Times Cited: 33
Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
Eustache Paramithiotis, Scott Sugden, Eszter Papp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Eustache Paramithiotis, Scott Sugden, Eszter Papp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 24
Psychological impact on healthcare workers, general population and affected individuals of SARS and COVID-19: A systematic review and meta-analysis
Teris Cheung, Calvin Pak Wing Cheng, Tommy Kwan Hin Fong, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24
Teris Cheung, Calvin Pak Wing Cheng, Tommy Kwan Hin Fong, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 24
Lack of Antinuclear Antibodies in Convalescent Coronavirus Disease 2019 Patients With Persistent Symptoms
Michael J. Peluso, Isaac J Thomas, Sadie E. Munter, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 11, pp. 2083-2084
Open Access | Times Cited: 24
Michael J. Peluso, Isaac J Thomas, Sadie E. Munter, et al.
Clinical Infectious Diseases (2021) Vol. 74, Iss. 11, pp. 2083-2084
Open Access | Times Cited: 24
Elevation of neural injury markers in patients with neurologic sequelae after hospitalization for SARS-CoV-2 infection
Michail Spanos, Sigal Shachar, Thadryan Sweeney, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104833-104833
Open Access | Times Cited: 15
Michail Spanos, Sigal Shachar, Thadryan Sweeney, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104833-104833
Open Access | Times Cited: 15
Mass spectrometry-based proteomics in basic and translational research of SARS-CoV-2 coronavirus and its emerging mutants
Yasmine Rais, Zhiqiang Fu, Andrei P. Drabovich
Clinical Proteomics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Yasmine Rais, Zhiqiang Fu, Andrei P. Drabovich
Clinical Proteomics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 19
Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery
Edda Santiago-Rodríguez, Andrés Maiorana, Michael J. Peluso, et al.
International Journal of Behavioral Medicine (2021) Vol. 29, Iss. 5, pp. 610-623
Open Access | Times Cited: 18
Edda Santiago-Rodríguez, Andrés Maiorana, Michael J. Peluso, et al.
International Journal of Behavioral Medicine (2021) Vol. 29, Iss. 5, pp. 610-623
Open Access | Times Cited: 18